Rhelion Life Sciences Corp. (CSE:RHEL)

Canada · Delayed Price · Currency is CAD

0.0250

0.00 (0.00%)

Oct 16, 2026, 3:28 PM EST

Rhelion Life Sciences Earnings Call Transcripts

Fiscal Year 2025

Earnings Call: Q4 2025
Revenue grew 4% to $4.9M with a 24% reduction in adjusted EBITDA loss, driven by cost discipline and a focus on functional mushroom products. Strong cash reserves, strategic asset sales, and a new Bitcoin treasury strategy position the company for controlled growth amid sector volatility.

Read full transcript →

Earnings release
Report
MD&A